feed,title,long_url,short_url
Motley,FDA Begins Priority Review of Axsome Therapeutics' Potential New Depression Drug,https://www.fool.com/investing/2021/04/26/fda-begins-priority-review-of-axsome-therapeutics/?source=iedfolrf0000001,https://j.mp/3xmOPX4
